10x Genomics (NASDAQ:TXG – Get Rating) posted its quarterly earnings results on Wednesday. The company reported ($0.44) EPS for the quarter, missing analysts’ consensus estimates of ($0.38) by ($0.06), Briefing.com reports. The company had revenue of $134.29 million during the quarter, compared to analyst estimates of $128.87 million. 10x Genomics had a negative return on […]
10x Genomics (NASDAQ:TXG – Get Rating) announced its quarterly earnings data on Wednesday. The company reported ($0.44) earnings per share for the quarter, missing the consensus estimate of ($0.38) by ($0.06), Briefing.com reports. 10x Genomics had a negative return on equity of 20.93% and a negative net margin of 32.15%. The firm had revenue of […]
Should You Buy or Sell 10x Genomics Stock? Get The Latest TXG Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.
Shares of 10x Genomics, Inc. (NASDAQ:TXG – Get Rating) have been assigned an average rating of “Hold” from the fourteen research firms that are covering the company, MarketBeat Ratings reports. Two analysts have rated the stock with a sell rating, two have assigned a hold rating and six have issued a buy rating on the […]
Stephens assumed coverage on shares of 10x Genomics (NASDAQ:TXG – Get Rating) in a report released on Thursday morning, The Fly reports. The brokerage issued an overweight rating and a $65.00 target price on the stock. A number of other research firms also recently weighed in on TXG. Canaccord Genuity Group increased their price target […]